MAIA Biotechnology Inc. (MAIA)
AMEX: MAIA
· Real-Time Price · USD
1.57
0.01 (0.64%)
At close: Aug 15, 2025, 3:59 PM
1.55
-1.27%
After-hours: Aug 15, 2025, 07:08 PM EDT
MAIA Biotechnology Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -16.17M | -19.7M | -23.25M | -25.94M | -28.08M | -23.72M | -19.77M | -18.63M | -17.69M | -16.47M | -15.77M | -13.54M | -14.82M | -14.97M | -12.58M | -12.97M | -8.5M | -5.04M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 2.32M | 1.93M | 1.91M | 2.58M | 2.7M | 2.9M | 3.09M | 2.22M | 2.18M | 2.14M | 2.32M | 2.44M | 2.69M | 2.88M | 2.72M | 3.96M | 3.48M | 2.71M |
Other Working Capital | 516.52K | -502.82K | -1.19M | -562.18K | 756.25K | 2.24M | 2.63M | 3.08M | 891.84K | 470.64K | 581.82K | -112.15K | 777.82K | 400.36K | 320.23K | 1.02M | 1.03M | 1.12M |
Other Non-Cash Items | -2.99M | 1.86M | 7.01M | 9.22M | 10.63M | 5.68M | 1.5M | 1.54M | 2.96M | 3.17M | 3.8M | 2.73M | 3.99M | 5.43M | 4.61M | 4.86M | 2.43M | 562.43K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.07M | -406.14K | -1.24M | -548.05K | 435.88K | 2.95M | 3.09M | 3.29M | 1.4M | 713.94K | 793.16K | 415.79K | 1.6M | 1.02M | 1.13M | 1.37M | 1.11M | 1.24M |
Operating Cash Flow | -15.77M | -16.32M | -15.7M | -15.79M | -15.42M | -13.3M | -13.07M | -11.59M | -12.75M | -12.47M | -11.66M | -10.75M | -7.75M | -6.42M | -4.12M | -2.79M | -1.48M | -527.58K |
Capital Expenditures | -5 | -1 | -5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 3.92M | 3.92M | 3.92M | 3.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | 3.92M | 4.26M | n/a | n/a | -3.92M | -4.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 117K | 5.01M | 7.43M | 7.71M | 7.59M | 2.7M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -166.51K | -301.21K | -578.1K | -1.09M | -927.29K | -2.42M | -2.15M | -2.14M | -3.5M | -1.99M | -1.84M | -350.46K | 890.49K | 1.01M | 860.43K | 3.77K | 3.77K | 3.77K |
Financial Cash Flow | 14.34M | 18.92M | 18.18M | 18.36M | 17.86M | 13.99M | 9.27M | 4.05M | 14.19M | 9.95M | 12.48M | 13.9M | 9.12M | 14.14M | 14.03M | 13.08M | 7.59M | 2.7M |
Net Cash Flow | -1.43M | 2.59M | 2.45M | 2.59M | 2.43M | 685.14K | -3.8M | -7.96M | 996.14K | -2.71M | 376.63K | 3.11M | 1.37M | 7.45M | 9.91M | 10.29M | 6.11M | 2.17M |
Free Cash Flow | -15.77M | -16.32M | -15.7M | -15.79M | -15.42M | -13.3M | -13.07M | -11.59M | -12.75M | -12.47M | -11.66M | -10.75M | -7.75M | -6.42M | -4.12M | -2.79M | -1.48M | -527.58K |